Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03378765 · ClinicalTrials.gov registry record
Gut Microbiota, Short Chain Fatty Acids, and Adiposity Across The Epidemiological Transition
A clinical trial of Obesity and Diabetes, sponsored by Loyola University.
- Active
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT03378765 is a study of Obesity and Diabetes that is active but no longer recruiting, run by Loyola University. The registered enrollment target is 2,000 participants, above the 817-participant average among 1,053 other Obesity trials with a reported enrollment target (145% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03378765, a study of Obesity and Diabetes, is active but no longer recruiting, sponsored by Loyola University.
- ACTIVE NOT RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to define associations between gut microbiota, SCFAs and obesity in populations spanning the epidemiologic transition, and explore mechanisms by which these factors may independently and collectively influence the development of obesity. The central hypothesis of this study is that the composition of gut microbiota drives SCFA production which in turn influences obesity risk at the population-level.
Interventions
- BEHAVIORAL Diet and physical activity monitoring
Study Locations (1)
Illinois
- Loyola University Chicago - Maywood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2018-01-02 |
| Est. Completion | 2025-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03378765
The ClinicalTrials.gov registry entry for NCT03378765 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 817-participant average among 1,053 other Obesity trials with a reported enrollment target (145% higher). The listed sponsor is Loyola University, which has 92 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Diet and physical activity monitoring is the first listed.
NCT03378765 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT03378765 about?
NCT03378765 is a clinical study titled "Gut Microbiota, Short Chain Fatty Acids, and Adiposity Across The Epidemiological Transition". The objective of this study is to define associations between gut microbiota, SCFAs and obesity in populations spanning the epidemiologic transition, and explore mechanisms by which these factors may independently and collectively influence the development of obesity. The central hypothesis of this ...
What is the current status of trial NCT03378765?
This trial is currently active not recruiting. The enrollment target is 2,000 participants. The study started on 2018-01-02. Estimated completion is 2025-03.
What conditions does trial NCT03378765 study?
This clinical trial studies the following conditions: Obesity, Diabetes.
What interventions are being tested in trial NCT03378765?
The interventions under investigation include: Diet and physical activity monitoring (BEHAVIORAL).
Who is sponsoring clinical trial NCT03378765?
This trial is sponsored by Loyola University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03378765 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.